| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 340.19M | 428.72M | 437.67M | 462.75M | 487.26M |
| Gross Profit | 310.99M | 399.04M | 389.59M | 405.09M | 487.43M |
| EBITDA | 126.40M | 111.80M | 227.43M | 200.53M | 360.78M |
| Net Income | 41.17M | 35.81M | 183.70M | 60.19M | 189.64M |
Balance Sheet | |||||
| Total Assets | 7.32B | 7.23B | 7.49B | 7.87B | 7.61B |
| Cash, Cash Equivalents and Short-Term Investments | 3.01B | 2.94B | 2.83B | 2.07B | 1.03B |
| Total Debt | 0.00 | 0.00 | 89.26M | 94.93M | 1.54M |
| Total Liabilities | 700.19M | 289.79M | 482.15M | 926.31M | 895.29M |
| Stockholders Equity | 6.62B | 5.77B | 5.84B | 5.75B | 5.61B |
Cash Flow | |||||
| Free Cash Flow | 250.93M | 405.76M | 991.36M | 1.04B | 441.02M |
| Operating Cash Flow | 251.61M | 408.85M | 998.65M | 1.05B | 469.27M |
| Investing Cash Flow | -209.93M | -8.45M | -89.28M | 172.14M | -590.38M |
| Financing Cash Flow | -68.60M | -228.04M | -146.06M | -45.39M | -124.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.91B | 9.33 | 0.89% | 3.28% | 9.64% | ― | |
69 Neutral | HK$566.23M | 5.92 | 4.26% | ― | 84.88% | 122.45% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | HK$1.72B | 18.39 | 1.63% | 2.14% | -20.02% | 10.62% | |
53 Neutral | HK$1.61B | 16.91 | -2.38% | ― | -45.13% | 60.10% | |
46 Neutral | HK$860.42M | -3.89 | -14.53% | ― | 173.24% | -515.63% | |
39 Underperform | HK$984.18M | -3.94 | 21.05% | ― | -78.40% | -196.19% |